Latest & greatest articles for constipation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on constipation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on constipation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for constipation

141. Use acupuncture to treat functional constipation: a meta-analysis of individual patient data

Use acupuncture to treat functional constipation: a meta-analysis of individual patient data Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2014 PROSPERO

142. Effect of fibre supplementation on chronic idiopathic constipation in adults: a systematic review and meta-analysis of randomised controlled trials

Effect of fibre supplementation on chronic idiopathic constipation in adults: a systematic review and meta-analysis of randomised controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2014 PROSPERO

143. Non-pharmacological therapies for patients with functional constipation

Non-pharmacological therapies for patients with functional constipation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2014 PROSPERO

144. Constipation

Constipation TREATMENT OF CONSTIPATION IN PREGNANCY 0344 892 0909 TREATMENT OF CONSTIPATION IN PREGNANCY (Date of issue: March 2018 , Version: 2 ) This is a UKTIS monograph for use by health care professionals. For case-specific advice please contact UKTIS on 0344 892 0909. To report an exposure please download and complete a . Please encourage all women to complete an . A corresponding patient information leaflet on is available at . Summary Constipation is common in pregnancy and affects (...) approximately 40% of women. It is thought to be caused by progesterone-induced intestinal smooth muscle relaxation. There is very little published epidemiological information available on the potential risks associated with the use of laxatives during pregnancy, however most have minimal systemic absorption and are commonly used during pregnancy without concerns regarding teratogenic effects being raised. Initial treatment of constipation in pregnancy should be non-pharmacological, e.g. exercise, dietary

2014 UK Teratology Information Service

145. Treatments for constipation: a review of systematic reviews

Treatments for constipation: a review of systematic reviews Treatments for constipation: a review of systematic reviews Treatments for constipation: a review of systematic reviews CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Treatments for constipation: a review of systematic reviews. Ottawa: Canadian Agency for Drugs (...) and Technologies in Health (CADTH). Rapid Response. 2014 Authors' conclusions In adults and children with chronic constipation, polyethylene glycol (PEG), increased the frequency of stools relative to placebo, lactulose and milk of magnesia. Stool frequency was also increased in adults treated with prucalopride versus placebo. Laxatives and prucalopride may increase the risk of diarrhea. No conclusions can be drawn with regards to stool softeners or bulking agents. The available studies were generally of lower

2014 Health Technology Assessment (HTA) Database.

146. Movantik (naloxegol) - To treat opioid-induced constipation in adults with chronic non-cancer pain

Movantik (naloxegol) - To treat opioid-induced constipation in adults with chronic non-cancer pain Drug Approval Package: Brand Name (Generic Name) NDA # Drug Approval Package U.S. Food & Drug Administration Search FDA Drug Approval Package - MOVANTIK (naloxegol) Tablets Company: AstraZeneca Pharmaceuticals LP Application No.: 204760 Approval Date: 9/16/2014 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. (PDF) (PDF) (PDF) (PDF

2014 FDA - Drug Approval Package

147. Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness

Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness CADTH Record Status This is a bibliographic record of a published (...) health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response. 2014 Authors' conclusions There remains a paucity of good quality evidence to support the use of docusate

2014 Health Technology Assessment (HTA) Database.

148. Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain. Full Text available with Trip Pro

Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain. Opioid-induced constipation is common and debilitating. We investigated the efficacy and safety of naloxegol, an oral, peripherally acting, μ-opioid receptor antagonist, for the treatment of opioid-induced constipation.In two identical phase 3, double-blind studies (study 04, 652 participants; study 05, 700 participants), outpatients with noncancer pain and opioid-induced constipation were randomly assigned to receive

2014 NEJM Controlled trial quality: predicted high

149. Management of faecal incontinence and constipation in adults with central neurological diseases. (Abstract)

Management of faecal incontinence and constipation in adults with central neurological diseases. People with central neurological disease or injury have a much higher risk of both faecal incontinence and constipation than the general population. There is often a fine line between the two symptoms, with any management intended to ameliorate one risking precipitating the other. Bowel problems are observed to be the cause of much anxiety and may reduce quality of life in these people. Current (...) strategies for faecal incontinence and constipation in people with a neurological disease or injury affecting the central nervous system.We searched the Cochrane Incontinence Group Trials Register (searched 8 June 2012), which includes searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and MEDLINE In-Process as well as handsearching of journals and conference proceedings; and all reference lists of relevant articles.Randomised and quasi-randomised trials evaluating any type

2013 Cochrane

150. Wireless motility capsule versus other diagnostic technologies for evaluating gastroparesis and constipation: a comparative effectiveness review

Wireless motility capsule versus other diagnostic technologies for evaluating gastroparesis and constipation: a comparative effectiveness review Wireless motility capsule versus other diagnostic technologies for evaluating gastroparesis and constipation: a comparative effectiveness review Wireless motility capsule versus other diagnostic technologies for evaluating gastroparesis and constipation: a comparative effectiveness review Stein E, Berger Z, Hutfless S, Shah L, Wilson LM, Haberl E, Bass (...) EB, Clarke JO Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Stein E, Berger Z, Hutfless S, Shah L, Wilson LM, Haberl E, Bass EB, Clarke JO. Wireless motility capsule versus other diagnostic technologies for evaluating gastroparesis and constipation: a comparative effectiveness review. Rockville: Agency for Healthcare Research and Quality

2013 Health Technology Assessment (HTA) Database.

151. Auriculotherapy in relieving symptoms of constipation and improving quality of life for the elderly: a pilot project. (Abstract)

Auriculotherapy in relieving symptoms of constipation and improving quality of life for the elderly: a pilot project. 23249851 2013 09 30 2016 10 20 1024-2708 18 Suppl 6 2012 Dec Hong Kong medical journal = Xianggang yi xue za zhi Hong Kong Med J Auriculotherapy in relieving symptoms of constipation and improving quality of life for the elderly: a pilot project. 30-3 Li M K MK School of Science and Technology, The Open University of Hong Kong, Hong Kong SAR, China. mkli@ouhk.edu.hk Lee T F D TF (...) Suen K P L KP eng Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't China Hong Kong Med J 9512509 1024-2708 IM Aged Aged, 80 and over Analysis of Variance Auriculotherapy Constipation therapy Feasibility Studies Female Humans Male Pilot Projects Quality of Life Single-Blind Method Time Factors 2012 12 20 6 0 2013 4 12 6 0 2013 10 1 6 0 ppublish 23249851

2013 Hong Kong medical journal = Xianggang yi xue za zhi Controlled trial quality: uncertain

152. Methylnaltrexone bromide (Relistor) for opioid-induced constipation

Methylnaltrexone bromide (Relistor) for opioid-induced constipation Methylnaltrexone bromide (Relistor) for opioid-induced constipation Methylnaltrexone bromide (Relistor) for opioid-induced constipation NIHR HSC Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NIHR HSC. Methylnaltrexone bromide (Relistor) for opioid-induced constipation (...) . Birmingham: NIHR Horizon Scanning Centre (NIHR HSC). Horizon Scanning Review. 2013 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Analgesics, Opioids; Constipation; Laxatives; Naltrexone Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health&Population Sciences, University

2013 Health Technology Assessment (HTA) Database.

153. Sacral nerve stimulation for constipation Full Text available with Trip Pro

Sacral nerve stimulation for constipation For over 10 years sacral nerve stimulation (SNS) has been used for patients with constipation resistant to conservative treatment. A review of the literature is presented.PubMed, MEDLINE and Embase databases were searched for studies demonstrating the use of SNS for the treatment of constipation.Thirteen studies have been published describing the results of SNS for chronic constipation. Of these, three were in children and ten in adults. Test (...) stimulation was successful in 42-100 per cent of patients. In those who proceeded to permanent SNS, up to 87 per cent showed an improvement in symptoms at a median follow-up of 28 months. The success of stimulation varied depending on the outcome measure being used. Symptom improvement correlated with improvement in quality of life and patient satisfaction scores.SNS appears to be an effective treatment for constipation, but this needs to be confirmed in larger prospective studies with longer follow-up

2013 EvidenceUpdates

154. A systematic review of the effectiveness of bowel management strategies for constipation in adults with stroke (Abstract)

A systematic review of the effectiveness of bowel management strategies for constipation in adults with stroke Constipation is one of the most common medical complications of acute stroke. Currently, management strategies to guide clinical practice are limited. This review aimed to examine the effectiveness of bowel management strategies for constipation in adults with stroke.A systematic review of randomised controlled trials or other quantitative research designs in the absence of randomised

2013 EvidenceUpdates

155. Constipation

Constipation American Gastroenterological Association If you're seeing this message, that means JavaScript has been disabled on your browser , please enable JS to make this app work.

2013 American Gastroenterological Association Institute

156. Coping with Common GI Symptoms in the Community: A Global Perspective on Heartburn, Constipation, Bloating, and Abdominal Pain/Discomfort

Coping with Common GI Symptoms in the Community: A Global Perspective on Heartburn, Constipation, Bloating, and Abdominal Pain/Discomfort © World Gastroenterology Organisation, 2013 World Gastroenterology Organisation Global Guidelines Coping with common GI symptoms in the community A global perspective on heartburn, constipation, bloating, and abdominal pain/discomfort May 2013 Review Team Richard Hunt (co-chair, Canada/UK) Eamonn Quigley (co-chair, USA) Zaigham Abbas (Pakistan) Abraham (...) 4.6.3 Primary care doctor 23 4.6.4 Specialist 24 5 Bloating 25 5.1 Definition and description 25 5.2 Epidemiological notes 26 5.3 Diagnostic/symptoms remarks 26 5.4 Differential diagnosis 27 5.5 Alarm features 27 5.6 Bloating—management cascade 27 5.6.1 Bloating self-help 27 5.6.2 Pharmacist 28 5.6.3 Primary care doctor 28 5.6.4 Specialist 29 6 Constipation 29 WGO Global Guidelines Common GI symptoms (long version) 3 © World Gastroenterology Organisation, 2013 6.1 Definition and description 29 6.2

2013 World Gastroenterology Organisation

157. Chinese herbal medcine for constipation in cancer patients

Chinese herbal medcine for constipation in cancer patients Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing

2013 PROSPERO

158. Specialist nursing interventions for chronic constipation

Specialist nursing interventions for chronic constipation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing

2013 PROSPERO

159. Irritable bowel syndrome with constipation in adults: linaclotide

Irritable bowel syndrome with constipation in adults: linaclotide Irritable bowel syndrome with constipation in Irritable bowel syndrome with constipation in adults: linaclotide adults: linaclotide Evidence summary Published: 9 April 2013 nice.org.uk/guidance/esnm16 pathways Ov Overview erview The content of this evidence summary was up-to-date in April 2013. See summaries of product characteristics (SPCs), British national formulary (BNF) or the MHRA or NICE websites for up- to-date (...) information. Key points from the evidence Linaclotide (Constella) is a first-in-class, oral, once-daily guanylate cyclase-C receptor agonist (GCCA), licensed for the symptomatic treatment of moderate-to-severe irritable bowel syndrome with constipation (IBS-C) in adults. It received a European marketing authorisation in November 2012 and is expected to be launched during the first half of 2013. Linaclotide has been evaluated in 2 double-blind, randomised, placebo-controlled trials of patients with IBS-C

2013 National Institute for Health and Clinical Excellence - Advice

160. Value of abdominal radiography, colonic transit time, and rectal ultrasound scanning in the diagnosis of idiopathic constipation in children: a systematic review Full Text available with Trip Pro

Value of abdominal radiography, colonic transit time, and rectal ultrasound scanning in the diagnosis of idiopathic constipation in children: a systematic review To perform a systematic review evaluating the value of abdominal radiography, colonic transit time (CTT), and rectal ultrasound scanning in the diagnosis of idiopathic constipation in children.Eligible studies were those assessing diagnostic accuracy of abdominal radiography, CTT, or rectal ultrasound scanning in children suspected (...) for idiopathic constipation. Methodological quality of the included studies was assessed with the Quality Assessment of studies of Diagnostic Accuracy included in Systematic reviews checklist.One systematic review summarized 6 studies on abdominal radiography until 2004. The additional 9 studies evaluated abdominal radiography (n = 2), CTT (n = 3), and ultrasound scanning (n = 4). All studies except two used a case-control study design, which will lead to overestimation of test accuracy. Furthermore, none

2012 EvidenceUpdates